PA-Clinical Pathology

Medicine & Life Sciences

1. Coronavirus 100%
2. Severe Acute Respiratory Syndrome 66%
3. SARS Virus 44%
4. Acute Myeloid Leukemia 41%
5. Plasma Exchange 39%
6. Microbiology 27%
7. Infections 22%
8. Pyuria 22%
9. Vaccines 21%
10. Bone Marrow 21%
11. Lenalidomide 20%
12. High-Throughput Nucleotide Sequencing 19%
13. Pandemics 19%
14. Metagenomics 19%
15. Hypersensitivity 18%
16. Fluorescence In Situ Hybridization 18%
17. Communicable Diseases 18%
18. Nucleocapsid 18%
19. Precursor Cell Lymphoblastic Leukemia-Lymphoma 17%
20. Urinary Tract Infections 17%
21. Clinical Decision Support Systems 17%
22. Vaccination 16%
23. Electronic Health Records 16%
24. Penicillins 15%
25. Pediatrics 15%
26. emicizumab 14%
27. Leukocyte Immunoglobulin-like Receptor B1 14%
28. Documentation 14%
29. Lymphoma 14%
30. prothrombin complex concentrates 13%
31. Microcystic adnexal carcinoma 13%
32. Routine Diagnostic Tests 12%
33. Acquired Factor 8 deficiency 12%
34. Polymerase Chain Reaction 12%
35. Therapeutics 12%
36. Streptococcus equi 12%
37. Inpatients 12%
38. Cranial Fontanelles 12%
39. B-Lymphocytes 11%
40. Anti-Bacterial Agents 11%
41. Prophylactic Mastectomy 11%
42. Tarsal Bones 11%
43. Medical Order Entry Systems 11%
44. Biomarkers 11%
45. Leukemia, Myelomonocytic, Chronic 11%
46. Sensitivity and Specificity 11%
47. Immunohistochemistry 11%
48. Artificial Intelligence 11%
49. Lactams 10%
50. von Willebrand Diseases 10%
51. Immunoglobulin G 10%
52. Phenotype 10%
53. Blood Component Removal 10%
54. Gene Fusion 10%
55. Meningitis 10%
56. Reptiles 10%
57. Thrombotic Thrombocytopenic Purpura 10%
58. Urine 10%
59. Antimicrobial Stewardship 10%
60. Cytogenetics 10%
61. Menorrhagia 10%
62. Brain Hypoxia-Ischemia 9%
63. Cefazolin 9%
64. Brain Abscess 9%
65. Hyphae 9%
66. Failure to Thrive 9%
67. Flow Cytometry 9%
68. Primary Myelofibrosis 9%
69. Hemangiosarcoma 9%
70. Paraproteinemias 9%
71. Central Nervous System Infections 9%
72. Decision Trees 9%
73. Erythrocyte Transfusion 9%
74. Ewing's Sarcoma 9%
75. Neoplasms 9%
76. Soft Tissue Infections 9%
77. Serology 9%
78. Hemorrhage 9%
79. Juvenile Arthritis 9%
80. Information Technology 9%
81. B-Cell Lymphoma 9%
82. Gene Targeting 9%
83. Mammaplasty 8%
84. Myasthenia Gravis 8%
85. Child 8%
86. Autoantibodies 8%
87. Proteins 8%
88. Hypertriglyceridemia 8%
89. Basal Cell Carcinoma 8%
90. Intracranial Hemorrhages 8%
91. Datasets 8%
92. Rituximab 8%
93. Osteomyelitis 8%
94. Non-Hodgkin's Lymphoma 8%
95. Cephalosporins 8%
96. Immunocompromised Host 8%
97. Warfarin 8%
98. Reverse Transcription 8%
99. Hydrocephalus 8%
100. Lymphadenopathy 7%